Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Significance of a Land Lawyer for Your Business - 2The most effective method to Perceive the Early Side effects of Cellular breakdown in the lungs
- 3Turkey’s intel chief lays out country’s vision for Middle East, world
- 4I took my shoes off and went for a barefoot hike. I couldn’t believe what happened next
- 5Revealing the Specialty of Food Matching: Improving Culinary Encounters
- Fossil analysis changes what paleontologists know about how long T. rex took to grow full size
- How to see the Ursids, the final meteor shower of 2025
- Australia to offer businesses $693 million in cheap loans to ease fuel cost pressure
- Dark matter may be made of pieces of giant, exotic objects — and astronomers think they know how to look for them
- Pick Your #1 game to observe
- Find the Techniques for Powerful Review Propensities: Opening Your Scholarly Potential
- Understanding Preschool Projects: An Extensive Aide
- 1st-ever disease gene fix, Alzheimer's blood test: 7 medical breakthroughs in 2025
- Smooth out Your Funds: Cash The board Simplified
